Wang Yang, He Yao, Li Bin-Shen, Wang Chao-Hui, Chen Zhi, Lu Miao-Long, Wen Zhi-Qiang, Chen Xiang
Department of Urology, Xiangya Hospital, Central South University , Changsha, China .
J Endourol. 2016 Mar;30(3):306-11. doi: 10.1089/end.2015.0526. Epub 2015 Nov 13.
To compare the operative outcomes of obese patients undergoing laparoendoscopic single-site (LESS) retroperitoneoscopic adrenalectomy or standard laparoscopic (LAP) retroperitoneoscopic adrenalectomy.
Between September 2011 and April 2015, 51 obese patients underwent LESS retroperitoneoscopic adrenalectomy and their operative outcomes were compared with 65 obese patients who underwent standard retroperitoneoscopic adrenalectomy by the same surgeon. In the LESS group, a single-port access was positioned in the lumbar incision. The standard retroperitoneal adrenalectomy technique was performed with a combination of conventional and curved LAP instruments. The following parameters were adopted: patient demographics, surgical details, perioperative complications, postoperative outcome data, and short-term outcomes.
The LESS group was comparable with the LAP group in terms of total operative time (70.4 ± 21.3 vs 65.5 ± 24.8 minutes, p = 0.26), hospital length of stay (5.7 ± 1.2 vs 6.1 ± 1.5 days, p = 0.12), and incidence of complications (4/51 vs 5/65, p = 0.98) for patients with similar baseline demographics. The LESS group had significantly shorter surgical incisions (2.8 ± 0.3 vs 5.3 ± 0.6 cm, p < 0.0001), lower in-hospital analgesic requirement (7.6 ± 3.3 mg morphine equivalent vs 10.5 ± 6.2 mg, p = 0.003), and significantly superior scar satisfaction score (9.3 ± 0.7 vs 7.6 ± 1.4, p < 0.0001) than the LAP group. Although estimated blood loss was greater in the LESS group (28.1 ± 10.6 vs 16.9 ± 7.2 mL in the LAP group, p < 0.0001), <50 mL overall blood loss was not clinically significant. During a mean follow-up of 20.2 months, no recurrences or deaths were documented in either group.
In properly selected patients, LESS retroperitoneoscopic adrenalectomy for obese individuals is technically feasible and safe in experienced hands, offering perioperative outcomes comparable with those of the conventional multiport approach, but with a superior cosmetic outcome.
比较肥胖患者接受经腹腔镜单孔(LESS)后腹腔镜肾上腺切除术与标准腹腔镜(LAP)后腹腔镜肾上腺切除术的手术效果。
2011年9月至2015年4月期间,51例肥胖患者接受了LESS后腹腔镜肾上腺切除术,并将其手术效果与同一位外科医生为65例肥胖患者实施的标准后腹腔镜肾上腺切除术的效果进行比较。在LESS组中,单孔通道位于腰部切口处。采用传统和弯曲的LAP器械相结合的方法实施标准后腹腔镜肾上腺切除术技术。采用以下参数:患者人口统计学资料、手术细节、围手术期并发症、术后结局数据和短期结局。
对于具有相似基线人口统计学特征的患者,LESS组与LAP组在总手术时间(70.4±21.3对65.5±24.8分钟,p = 0.26)、住院时间(5.7±1.2对6.1±1.5天,p = 0.12)和并发症发生率(分别为4/51和5/65,p = 0.98)方面相当。LESS组的手术切口明显更短(2.8±0.3对5.3±0.6 cm,p < 0.0001),住院期间镇痛需求更低(吗啡当量为7.6±3对10.5±6.2 mg,p = 0.003)且瘢痕满意度评分明显更高(9.3±0.7对7.6±1.4,p < 0.0001)。虽然LESS组的估计失血量更大(LESS组为28.1±10.6 mL,LAP组为16.9±7.2 mL,p < 0.0001),但总体失血量<50 mL在临床上无显著意义。在平均20.2个月的随访期间,两组均未记录到复发或死亡病例。
在经过适当选择的患者中,经验丰富的医生对肥胖个体实施LESS后腹腔镜肾上腺切除术在技术上是可行且安全的,其围手术期效果与传统多通道手术相当,但美容效果更佳。